SREBF1 and fatty liver disease: Bioinformatic analysis predicted a conserved miR-18a-5p binding site in the 3′ UTR of SREBP1c (Zhang et al., 2019), supporting our hypothesis that downregulation of miR-18a-5p contributes to increased hepatic SREBP1c expression and, consequently, enhanced lipogenesis and hepatic steatosis (Ju et al., 2020; Wang et al., 2015; Zhao et al., 2018).